Literature DB >> 10668900

Inflammation and stroke: putative role for cytokines, adhesion molecules and iNOS in brain response to ischemia.

G del Zoppo1, I Ginis, J M Hallenbeck, C Iadecola, X Wang, G Z Feuerstein.   

Abstract

Ischemic stroke is a leading cause of death and disability in developed countries. Yet, in spite of substantial research and development efforts, no specific therapy for stroke is available. Several mechanism for neuroprotection have been explored including ion channels, excitatory amino acids and oxygen radicals yet none has culminated in an effective therapeutic effect. The review article on "inflammation and stroke" summarizes key data in support for the possibility that inflammatory cells and mediators are important contributing and confounding factors in ischemic brain injury. In particular, the role of cytokines, endothelial cells and leukocyte adhesion molecules, nitric oxide and cyclooxygenase (COX-2) products are discussed. Furthermore, the potential role for certain cytokines in modulation of brain vulnerability to ischemia is also reviewed. The data suggest that novel therapeutic strategies may evolve from detailed research on some specific inflammatory factors that act in spatial and temporal relationships with traditionally recognized neurotoxic factors. The dual nature of some mediators in reformatting of brain cells for resistance or sensitivity to injury demonstrate the delicate balance needed in interventions based on anti-inflammatory strategies.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10668900     DOI: 10.1111/j.1750-3639.2000.tb00247.x

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  179 in total

1.  Brain tissue responses to ischemia.

Authors:  J M Lee; M C Grabb; G J Zipfel; D W Choi
Journal:  J Clin Invest       Date:  2000-09       Impact factor: 14.808

2.  Vitamin D deficiency exacerbates experimental stroke injury and dysregulates ischemia-induced inflammation in adult rats.

Authors:  Robyn Balden; Amutha Selvamani; Farida Sohrabji
Journal:  Endocrinology       Date:  2012-03-09       Impact factor: 4.736

3.  Optimization of multiplexed bead-based cytokine immunoassays for rat serum and brain tissue.

Authors:  R E Hulse; P E Kunkler; J P Fedynyshyn; R P Kraig
Journal:  J Neurosci Methods       Date:  2004-06-15       Impact factor: 2.390

Review 4.  Human cellular inflammation in the pathology of acute cerebral ischaemia.

Authors:  C J S Price; E A Warburton; D K Menon
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-11       Impact factor: 10.154

Review 5.  Revisiting the timing hypothesis: biomarkers that define the therapeutic window of estrogen for stroke.

Authors:  Farida Sohrabji; Amutha Selvamani; Robyn Balden
Journal:  Horm Behav       Date:  2012-06-19       Impact factor: 3.587

6.  Slit modulates cerebrovascular inflammation and mediates neuroprotection against global cerebral ischemia.

Authors:  Tamer Altay; Bethann McLaughlin; Jane Y Wu; T S Park; Jeffrey M Gidday
Journal:  Exp Neurol       Date:  2007-07-26       Impact factor: 5.330

7.  L-arginine and Alzheimer's disease.

Authors:  Jing Yi; Laura L Horky; Avi L Friedlich; Ying Shi; Jack T Rogers; Xudong Huang
Journal:  Int J Clin Exp Pathol       Date:  2008-10-02

Review 8.  Intrinsic regulation of brain inflammatory responses.

Authors:  Elena Galea; Michael T Heneka; Cinzia Dello Russo; Douglas L Feinstein
Journal:  Cell Mol Neurobiol       Date:  2003-10       Impact factor: 5.046

9.  Glia maturation factor deficiency suppresses 1-methyl-4-phenylpyridinium-induced oxidative stress in astrocytes.

Authors:  Mohammad Moshahid Khan; Duraisamy Kempuraj; Smita Zaheer; Asgar Zaheer
Journal:  J Mol Neurosci       Date:  2014-01-16       Impact factor: 3.444

10.  Tenoxicam exerts a neuroprotective action after cerebral ischemia in rats.

Authors:  Rita I M Galvão; João P L Diógenes; Graziela C L Maia; Emídio A S Filho; Silvânia M M Vasconcelos; Dalgimar B de Menezes; Geanne M A Cunha; Glauce S B Viana
Journal:  Neurochem Res       Date:  2005-01       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.